Psychological distress, perceived health status, and physician utilization in America and west Germany

1988 ◽  
Vol 26 (8) ◽  
pp. 829-838 ◽  
Author(s):  
William C. Cockerham ◽  
Gerhard Kunz ◽  
Guenther Lueschen
2009 ◽  
Vol 54 (8) ◽  
pp. 526-533 ◽  
Author(s):  
Norbert Schmitz ◽  
Alain Lesage ◽  
JianLi Wang

Objective: Psychological distress questionnaires are often used as screening instruments for mental disorders in clinical and epidemiologic settings. Poor physical health may affect the screening properties of a questionnaire. We evaluate the effect of self-perceived health status on the screening performance of the Kessler K10 and K6 scales in a community sample. Methods: We used data from the Canadian Community Health Survey: Mental Health and Well-Being (CCHS 1.2). Psychological distress was measured by the 6–item (K6) and the 10–item (K10) Kessler instrument. Depression and anxiety disorders were assessed using the World Mental Health Composite International Diagnostic Interview (1–month estimates). Optimal cut-off points regarding health status were determined by finding the K6 and K10 values that allowed for the best balance between sensitivity and specificity. Stratum-specific likelihood ratios (SSLRs) were computed to define strata with discriminating power. Results: There was a strong association between the screening performance of the K6 and K10 scales and self-perceived health status: for the K10 scale, a cut-off point of 5/6 yielded the best balance between sensitivity and specificity for subjects with excellent or very good health status, while a cut-off point of 14/15 yielded the best balance between sensitivity and specificity for subjects with poor health status. Conclusions: The combination of the K6 and K10 scales, with a self-rated health status item, may improve screening properties of the 2 scales.


2021 ◽  
Author(s):  
Marta Linares-Moya ◽  
Janet Rodríguez-Torres ◽  
Alejandro Heredia-Ciuró ◽  
María Granados-Santiago ◽  
Laura López-López ◽  
...  

Abstract Purpose Patients with lung cancer experience a variety of distressing symptoms which could adversely quality of life. The aim of this study was to determine whether psychological distress prior to surgery is associated with health status and symptom burden in lung cancer survivors. Methods A longitudinal observational study with one-year follow‐up was carried out. Health status was measured by the WHO Disability Assessment Scale (WHO-DAS 2.0), the Euroqol-5 dimensions (EQ-5D) and the Pittsburgh Sleep Quality Index (PSQI). Symptoms severity included dyspnoea (Multidimensional Profile of Dyspnoea); pain (Brief Pain Inventory); fatigue (Fatigue Severity Scale) and cough (Leicester Cough Questionnaire). Results 174 lung cancer patients were included. Patients in the group with psychological distress presented a worse self-perceived health status, functionality and sleep quality. The group with psychological distress also presented higher dyspnea, fatigue and pain. Conclusion Patients with psychological distress prior surgery present a greater symptom burden and a poorer self-perceived health status, lower functionality and sleep quality, than patients without distress one year after the lung resection.


Author(s):  
Marta Linares-Moya ◽  
Janet Rodríguez-Torres ◽  
Alejandro Heredia-Ciuró ◽  
María Granados-Santiago ◽  
Laura López-López ◽  
...  

Abstract Purpose Patients with lung cancer experience a variety of distressing symptoms which could adversely affect quality of life. The aim of this study was to determine whether psychological distress prior to surgery is associated to health status and symptom burden in lung cancer survivors. Methods A longitudinal observational study with 1‐year follow‐up was carried out. Health status was measured by the WHO Disability Assessment Scale (WHO-DAS 2.0), the Euroqol-5 dimensions (EQ-5D) and the Pittsburgh Sleep Quality Index (PSQI). Symptoms severity included dyspnoea (Multidimensional Profile of Dyspnoea); pain (Brief Pain Inventory); fatigue (Fatigue Severity Scale); and cough (Leicester Cough Questionnaire). Results One hundred seventy-four lung cancer patients were included. Patients in the group with psychological distress presented a worse self-perceived health status, functionality and sleep quality. The group with psychological distress also presented higher dyspnoea, fatigue and pain. Conclusion Patients with psychological distress prior surgery present with a greater symptom burden and a poorer self-perceived health status, lower functionality and sleep quality, than patients without distress 1 year after the lung resection.


2019 ◽  
Vol 3 (1) ◽  
Author(s):  
A. Barnadas ◽  
◽  
M. Muñoz ◽  
M. Margelí ◽  
J. I. Chacón ◽  
...  

Abstract Background Bone metastasis (BM) is the most common site of disease in metastatic breast cancer (MBC) patients. BM impacts health-related quality of life (HRQoL). We tested prospectively the psychometric properties of the Bone Metastasis Quality of Life (BOMET-QoL-10) measure on MBC patients with BM. Methods Patients completed the BOMET-QoL-10 questionnaire, the Visual Analogue Scale (VAS) for pain, and a self-perceived health status item at baseline and at follow-up visits. We performed psychometric tests and calculated the effect size of specific BM treatment on patients´ HRQoL. Results Almost 70% of the 172 patients reported symptoms, 23.3% experienced irruptive pain, and over half were receiving chemotherapy. BOMET-QoL-10 proved to be a quick assessment tool performing well in readability and completion time (about 10 min) with 0–1.2% of missing/invalid data. Although BOMET-QoL-10 scores remained fairly stable during study visits, differences were observed for patient subgroups (e.g., with or without skeletal-related events or adverse effects). Scores were significantly correlated with physician-reported patient status, patient-reported pain, symptoms, and perceived health status. BOMET-QoL-10 scores also varied prospectively according to changes in pain intensity. Conclusions BOMET-QoL-10 performed well as a brief, easy-to-administer, useful, and sensitive HRQoL measure for potential use for clinical practice with MBC patients. Trial registration NCT03847220. Retrospectively registered on clinicaltrials.gov (February the 20th 2019).


2013 ◽  
Vol 16 (3) ◽  
pp. A251
Author(s):  
W. Agbor Bawa ◽  
N. Rianon ◽  
R. Rasu

Sign in / Sign up

Export Citation Format

Share Document